EDSA Edesa Biotech Inc
Price (delayed)
$2.45
Market cap
$16.99M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.87
Enterprise value
$15.43M
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05
Highlights
EDSA's debt has dropped by 100% since the previous quarter and by 100% year-on-year
Edesa Biotech's EPS has increased by 28% YoY and by 3.1% from the previous quarter
The equity has dropped by 61% year-on-year but it has increased by 14% since the previous quarter
The quick ratio has shrunk by 60% YoY but it is up by 42% QoQ
Key stats
What are the main financial stats of EDSA
Market
Valuations
Earnings
Shares outstanding
6.94M
Market cap
$16.99M
Enterprise value
$15.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.75
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$7.06M
Net income
-$6.11M
EBIT
-$6.11M
EBITDA
-$5.92M
Free cash flow
-$5M
Per share
Balance sheet
Liquidity
EPS
-$1.87
EPS diluted
-$1.87
Free cash flow per share
-$1.49
Book value per share
$0.65
Revenue per share
$0
TBVPS
$0.63
Total assets
$4.16M
Total liabilities
$1.9M
Debt
$0
Equity
$2.26M
Working capital
$171,709
Debt to equity
0
Current ratio
1.09
Quick ratio
1.01
Net debt/EBITDA
0.26
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-124.2%
Return on equity
-213.7%
Return on invested capital
N/A
Return on capital employed
-269.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EDSA stock price
How has the Edesa Biotech stock price performed over time
Intraday
5.6%
1 week
-3.45%
1 month
11.87%
1 year
-44.32%
YTD
45.83%
QTD
0.41%
Financial performance
How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.06M
Net income
-$6.11M
Gross margin
N/A
Net margin
N/A
EDSA's net income is up by 21% year-on-year
Edesa Biotech's operating income has increased by 19% YoY
Growth
What is Edesa Biotech's growth rate over time
Valuation
What is Edesa Biotech stock price valuation
P/E
N/A
P/B
3.75
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has increased by 28% YoY and by 3.1% from the previous quarter
The equity has dropped by 61% year-on-year but it has increased by 14% since the previous quarter
EDSA's price to book (P/B) is 19% lower than its 5-year quarterly average of 4.4 and 19% lower than its last 4 quarters average of 4.4
Efficiency
How efficient is Edesa Biotech business performance
The company's return on equity has shrunk by 106% YoY and by 30% QoQ
Edesa Biotech's return on assets has decreased by 48% YoY and by 18% QoQ
Dividends
What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EDSA.
Financial health
How did Edesa Biotech financials performed over time
Edesa Biotech's total assets is 119% more than its total liabilities
The quick ratio has shrunk by 60% YoY but it is up by 42% QoQ
EDSA's current ratio has shrunk by 60% YoY but it is up by 20% QoQ
EDSA's debt is 100% smaller than its equity
EDSA's debt to equity has dropped by 100% since the previous quarter and by 100% year-on-year
EDSA's debt has dropped by 100% since the previous quarter and by 100% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.